证券记录 · 已归档季度
FOLD
Amicus Therapeutics, Inc. · Healthcare · Biotechnology
13被追踪持有人
+2Δ持有人
42.84M持有股份
$457.59M报告持仓市值
+2新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +18.2% ·
股份流向 +10.3% ·
净新建仓位 +15.4%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q1 2026 | 106 | -6 | 206.15M | $2.98B | +6 | −13 |
| Q4 2025 | 112 | +4 | 192.14M | $2.74B | +5 | — |
| Q3 2025 | 19 | -1 | 150.66M | $1.19B | — | −2 |
| Q2 2025 | 18 | 0 | 135.88M | $778.62M | — | — |
| Q1 2025 | 15 | +2 | 70.64M | $576.46M | +2 | — |
| Q4 2024 | 13 | -1 | 63.65M | $599.56M | — | −1 |
| Q3 2024 | 13 | +2 | 42.84M | $457.59M | +2 | — |
| Q2 2024 | 11 | — | 38.85M | $385.40M | — | — |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 23.96M | +13.5% | $255.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 23.96M | +13.5% | $255.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 23.96M | +13.5% | $255.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 23.96M | +13.5% | $255.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 23.96M | +13.5% | $255.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 23.96M | +13.5% | $255.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 23.96M | +13.5% | $255.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Geode Capital Management ✦ (被动) | 6.60M | +1.2% | $70.50M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Geode Capital Management ✦ (被动) | 6.60M | +1.2% | $70.50M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 3.63M | +20.3% | $38.77M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 3.63M | +20.3% | $38.77M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Norges Bank ✦ (被动) | 2.92M | 0.0% | $31.24M | 0.0% | Held | 2 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 1.34M | -3.5% | $14.33M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 1.34M | -3.5% | $14.33M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 1.27M | 新增 | $13.53M | 0.0% | New | 1 | SEC ↗ |
| 16 | PRIMECAP Management ✦ | 1.03M | -2.2% | $10.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 769.30K | +21.7% | $8.22M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 670.44K | +651.0% | $7.16M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Millennium Management ✦ | 412.56K | -78.2% | $4.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 125.96K | -7.0% | $1.35M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 88.85K | +1.4% | $948,875 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 88.85K | +1.4% | $948,875 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | Marshall Wace ✦ | 20.60K | 新增 | $220,008 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $13.53M | 0.0% |
| Marshall Wace | $220,008 | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 296 持有人, 325.04M 股份, $4.48B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据